Literature DB >> 15887863

Acromegaly due to a growth hormone-releasing hormone-secreting intracranial gangliocytoma.

M L Isidro1, P Iglesias Díaz, X Matías-Guiu, F Cordido.   

Abstract

In more than 95% of cases acromegaly is due to GH hypersecretion by a pituitary adenoma. GHRH hypersecretion accounts for about 0.5% of cases of acromegaly. Intracranial GHRH-secreting tumors are extremely rare and only a few well-documented cases have been reported. The clinical features of acromegaly due to intracranial GHRH-secreting tumor are indistinguishable from those of other patients with "classical acromegaly". In cases of intrasellar gangliocytomas, not even radiological findings help to make the correct diagnosis, which can only be made with the hystological study. We present the case of a woman with acromegaly; the magnetic resonance demonstrated a 2x1.8x1.2 cm mass in the jugum sphenoidalis region, associated with a partial empty sella. There was a partial response to high-dose lanreotide therapy, so surgical treatment was decided, although only part of the tumor could be removed. Histopathological diagnosis was consistent with gangliocytoma, and immunostaining in the ganglionic cells was positive for GHRH. After surgery, hormone hypersecretion persisted, so medical treatment was reintroduced. In summary, we report a well-documented case of an intracranial GHRH-secreting gangliocytoma, an exceedingly rare cause of acromegaly. Clinical and biochemical data did not allow to make the correct diagnosis, which was only made on the pathological study. This case underscores that acromegaly can be due to causes other than a GH-secreting adenoma, and underlines that finding an image not typical of a pituitary adenoma should raise the suspicion that an unusual cause subsides the acromegaly.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15887863     DOI: 10.1007/bf03345360

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  10 in total

1.  Pituitary gangliocytoma-adenoma presenting with acromegaly: response to treatment.

Authors:  V Luna; F Morales; L M Luengo; A Sanz; J Diaz
Journal:  Arch Intern Med       Date:  2001-04-09

Review 2.  Pathophysiology and clinical aspects of the ectopic GH-releasing hormone syndrome.

Authors:  M Losa; K von Werder
Journal:  Clin Endocrinol (Oxf)       Date:  1997-08       Impact factor: 3.478

3.  Intrasellar gangliocytomas associated with acromegaly.

Authors:  Masamichi Kurosaki; Wolfgang Saeger; Dieter K Lüdecke
Journal:  Brain Tumor Pathol       Date:  2002       Impact factor: 3.298

4.  Gangliocytoma masquerading as a prolactinoma. Case report.

Authors:  K C McCowen; J N Glickman; P M Black; N T Zervas; H G Lidov; J R Garber
Journal:  J Neurosurg       Date:  1999-09       Impact factor: 5.115

5.  'Gangliocytomas' of the pituitary: a heterogeneous group of lesions with differing histogenesis.

Authors:  J F Geddes; G H Jansen; S F Robinson; E Gömöri; J L Holton; J P Monson; G M Besser; T Révész
Journal:  Am J Surg Pathol       Date:  2000-04       Impact factor: 6.394

6.  Neuroendocrine tumors in the brain.

Authors:  P Cavalla; D Schiffer
Journal:  Ann Oncol       Date:  2001       Impact factor: 32.976

7.  A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor.

Authors:  S L Asa; B W Scheithauer; J M Bilbao; E Horvath; N Ryan; K Kovacs; R V Randall; E R Laws; W Singer; J A Linfoot
Journal:  J Clin Endocrinol Metab       Date:  1984-05       Impact factor: 5.958

Review 8.  Ectopic acromegaly.

Authors:  G Faglia; M Arosio; N Bazzoni
Journal:  Endocrinol Metab Clin North Am       Date:  1992-09       Impact factor: 4.741

Review 9.  Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations.

Authors:  T Sano; S L Asa; K Kovacs
Journal:  Endocr Rev       Date:  1988-08       Impact factor: 19.871

Review 10.  Gangliocytomas of the sellar region--a review.

Authors:  M J Puchner; D K Lüdecke; W Saeger; M Riedel; S L Asa
Journal:  Exp Clin Endocrinol Diabetes       Date:  1995       Impact factor: 2.949

  10 in total
  9 in total

1.  An intrasellar mixed gangliocytoma-adenoma including ependymal component, and review of the literature.

Authors:  Ping Xiao; Ling Xue; Jian-Jun Peng; Shi-Ting Feng; Bing Liao; Jian-Ming Wen
Journal:  BMJ Case Rep       Date:  2009-04-07

Review 2.  Infrasellar pituitary gangliocytoma causing Cushing's syndrome.

Authors:  Marie-Eve Domingue; Etienne Marbaix; Jean-Luc Do Rego; Vincent Col; Christian Raftopoulos; Thierry Duprez; Hubert Vaudry; Dominique Maiter
Journal:  Pituitary       Date:  2015-10       Impact factor: 4.107

3.  Ectopic acromegaly due to a growth hormone-secreting neuroendocrine-differentiated tumor developed from ovarian mature cystic teratoma.

Authors:  Mesut Ozkaya; Zeynel Abidin Sayiner; Gurkan Kiran; Kamile Gul; Ibrahim Erkutlu; Umut Elboga
Journal:  Wien Klin Wochenschr       Date:  2015-04-14       Impact factor: 1.704

4.  Acromegaly associated with gangliocytoma.

Authors:  R K Crowley; Y Al-Derazi; K Lynch; D Rawluk; C J Thompson; M Farrell; A Agha
Journal:  Ir J Med Sci       Date:  2009-09-30       Impact factor: 1.568

5.  Clinical manifestations and diagnosis of acromegaly.

Authors:  Gloria Lugo; Lara Pena; Fernando Cordido
Journal:  Int J Endocrinol       Date:  2012-02-01       Impact factor: 3.257

Review 6.  Acromegaly: a challenging condition to diagnose.

Authors:  Salma AlDallal
Journal:  Int J Gen Med       Date:  2018-08-24

Review 7.  Pituitary Gangliocytoma Producing TSH and TRH: A Review of "Gangliocytomas of the Sellar Region".

Authors:  Kiyohiko Sakata; Kana Fujimori; Satoru Komaki; Takuya Furuta; Yasuo Sugita; Kenji Ashida; Masatoshi Nomura; Motohiro Morioka
Journal:  J Clin Endocrinol Metab       Date:  2020-10-01       Impact factor: 5.958

8.  Observation of Clinicopathologic Features of Pituitary Adenoma With Neuronal Differentiation.

Authors:  Limei Zheng; Xiaorong Yan; Chengcong Hu; Peng Zhang; Yupeng Chen; Qiaoyan Zheng; Liwen Hu; Mi Wang; Guoping Li; Ping Wu; Changzhen Jiang; Jing Tian; Sheng Zhang; Xingfu Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-15       Impact factor: 5.555

9.  Unilateral hydrocephalus from a gangliocytoma-somatotrophinoma: first reported case.

Authors:  Simon Ryder; Jed Robusto; Thomas Robertson; Hamish Alexander; Emma L Duncan
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2021-07-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.